Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · Real-Time Price · USD
11.00
+0.32 (3.05%)
Mar 9, 2026, 1:27 PM EDT - Market open

Phathom Pharmaceuticals Market Cap

Phathom Pharmaceuticals has a market cap or net worth of $866.39 million as of March 9, 2026. Its market cap has increased by 128.71% in one year.

Market Cap
866.39M
Enterprise Value
1.33B
1-Year Change
128.71%
Ranking
Category
Stock Price
$11.00

Market Cap Chart

Since October 25, 2019, Phathom Pharmaceuticals's market cap has increased from $527.13M to $866.39M, an increase of 64.36%. That is a compound annual growth rate of 8.12%.

History

DateMarket Cap% Change
Mar 6, 2026840.78M-28.76%
Dec 31, 20251.18B112.56%
Dec 31, 2024555.22M6.22%
Dec 29, 2023522.72M13.23%
Dec 30, 2022461.63M-22.48%
Dec 31, 2021595.53M-36.35%
Dec 31, 2020 Pro Pro
Dec 31, 2019 Pro Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Arbutus Biopharma 871.23M
Arvinas 869.87M
Janux Therapeutics 841.91M
Sana Biotechnology 840.63M
Evommune 835.39M
BridgeBio Oncology Therapeutics 833.94M
Xencor 830.19M
KalVista Pharmaceuticals 820.37M
Market Cap Rankings